Viraferonpeg and erythema Patient Reports February 11, 2012



Viraferonpeg Side Effects Report #5258677-7
Viraferonpeg side effect was reported by a Physician from FRANCE on Feb 23, 2007. Male patient, 53 years of age, was diagnosed with malignant melanoma and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, erythema, necrosis, pain in extremity, peripheral ischaemia, vasculitis What is  vasculitis, venous thrombosis. Viraferonpeg dosage: unknown. During the same period patient was treated with IDD. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4786011-5
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 21, 2005. Female patient, 76 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaesthetic complication neurological, blood gases abnormal, brain natriuretic peptide increased, cardiac failure, dependence on respirator, erythema, escherichia urinary tract infection, fatigue. Viraferonpeg dosage: 0.45 ML QW. During the same period patient was treated with REBETOL, MANTADIX, FUROSEMIDE, COVERSYL, FLECAINIDE ACETATE, KALEORID, SERETIDE. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5903373-3
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 23, 2008. Female patient, 60 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: disease recurrence, erythema, leukaemia. Viraferonpeg dosage: 0.5 MG;. During the same period patient was treated with REBETOL. Patient recovered.

Viraferonpeg Side Effects Report #4593980-5
Viraferonpeg side effect was reported by a Physician from on Feb 09, 2005. Male patient, 41 years of age, weighting 207.2 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: abdominal pain upper, chills, erythema, hepatitis c rna positive, hypersensitivity, loss of consciousness, malaise, palpitations, syncope. Viraferonpeg dosage: unknown. During the same period patient was treated with RIBAVIRIN, RABEPRAZOLE. Patient recovered.


Viraferonpeg Side Effects Report #4883104-9
Viraferonpeg side effect was reported by a Physician from FRANCE on Jan 05, 2006. Male patient, 33 years of age, weighting 183.0 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: erythema, feeling hot, injection site necrosis, injection site reaction, lymphadenopathy, necrotising panniculitis, oedema peripheral, pain in extremity, post procedural complication. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4556524-X
Viraferonpeg side effect was reported by a Physician from on Jan 05, 2005. Male patient was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: chest pain What is  chest pain, condition aggravated, erythema, hepatitis c What is  hepatitis c, loss of consciousness, malaise, palpitations, syncope, transaminases increased. Viraferonpeg dosage: unknown. Patient recovered.

Viraferonpeg Side Effects Report #4664772-3
Viraferonpeg side effect was reported by a Physician from on May 12, 2005. Male patient, 40 years of age, weighting 231.5 lb, was diagnosed with chronic hepatitis and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arthralgia, erythema, headache What is  headache, hyperaesthesia, hyperthermia, inflammation, influenza, injection site reaction, myalgia. Viraferonpeg dosage: 0.5 ML SUBCUTANEOUS. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Viraferonpeg